(Q44612173)

4 December 2017

Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity (English)

1 reference

4 December 2017

1 reference

1 reference

6

Gerald I Shulman

1 reference

4 December 2017

5

Jason K Kim

1 reference

4 December 2017

Shamina M Rangwala

1

1 reference

4 December 2017

Ben Rhoades

2

1 reference

4 December 2017

Jennifer S Shapiro

3

1 reference

4 December 2017

A Sophie Rich

4

1 reference

4 December 2017

Klaus H Kaestner

7

1 reference

4 December 2017

Mitchell A Lazar

8

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

4 December 2017

7

1 reference

inferred from page(s)

published in

Developmental Cell

1 reference

4 December 2017

5

1 reference

4 December 2017

4

1 reference

4 December 2017

657-663

1 reference

Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Adipose tissue as an endocrine organ

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

PPAR gamma is required for placental, cardiac, and adipose tissue development

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

An adipogenic cofactor bound by the differentiation domain of PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

A war on obesity, not the obese.

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

A futile metabolic cycle activated in adipocytes by antidiabetic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

The Pro115Gln polymorphism within the PPAR gamma2 gene has no epidemiological impact on morbid obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Effect of heterozygous PPARgamma deficiency and TZD treatment on insulin resistance associated with age and high-fat feeding

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

PPAR gamma and the treatment of insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Mechanisms by which Thiazolidinediones Enhance Insulin Action

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Obesity associated with a mutation in a genetic regulator of adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Interdomain communication regulating ligand binding by PPAR-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1534-5807%2803%2900274-0

7 January 2021

10.1016/S1534-5807(03)00274-0

Identifiers

DOI

1 reference

4 December 2017

1 reference